Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Complex Cases From the Collection of Dr. Samuel Moschella
Description
In a presentation at the Leahy Clinic, Adam Lipworth honors Dr. Samuel Moschella, discussing his dedication to Hansen's disease and the care of marginalized patients during his 70-year career. Starting with a case of lepromatous leprosy, Lipworth highlights Moschella's journey to understanding and addressing this complex disease after encountering a patient with unusual skin plaques while in Guantanamo. This incident spurred him to seek mentorship, leading to the discovery of multiple other undiagnosed cases on the base. Throughout his career, Moschella founded seminar series and clinics, training over 2,000 residents in Hansen's disease care and advocating for marginalized populations suffering from the stigma associated with it. The presentation details the psychosocial impact of the disease, its classification systems, skin manifestations, and reactions, emphasizing its challenges. Lipworth underlines the need for sensitivity towards patients and the importance of collaboration in managing Hansen's disease, as it remains a global health challenge with significant implications for those affected.
View moreConclusions
- The presentation highlights the significant contributions of Dr. Samuel Moschella to the understanding and treatment of Hansen's disease (leprosy).
- Hansen's disease is primarily a disease of the marginalized and disenfranchised, resulting in stigma and severe psychosocial effects.
- There is a critical need for ongoing research and treatment approaches to address the challenges posed by the complex nature of Hansen's disease.
- Current data show increasing incidence rates of Hansen's disease, indicating that global elimination efforts have not yet succeeded.
- Proper terminology is essential; the term 'leprosy' carries stigma, while 'Hansen's disease' is preferred to reduce discrimination.
- Effective treatment regimens include multidrug therapy, with awareness of potential reactions necessary for better patient management.
- Education and training in Hansen's disease are crucial for healthcare professionals to improve care for this underserved population.
- Rao PS, Darlong F, Timothy M, Kumar S, Abraham S, Kurian R. Disability adjusted working life years (DAWLYs) of leprosy affected persons in India. Indian J Med Res. 2013 May;137(5):907-10
- Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A New Mycobacterium Species Causing Diffuse Lepromatous Leprosy. Am J Clin Pathol. 2008;130:856-64.
- Deps P, Cruz A. Why we should stop using the word leprosy. Lancet Infect Dis. 2020; 20: e75-78.
- L. Walker, Stephen; M. Sales, Anna; Ruth Butlin, C.; Shah, Mahesh; Maghanoy, Armi; M. Lambert, Saba; et al. (2017): ENLIST ENL Severity Scale. PLOS Neglected Tropical Diseases. Journal contribution. https://doi.org/10.1371/journal.pntd.0005716.s001
- World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017.